Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Crinetics Pharmaceuticals, Inc. (CRNX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Crinetics Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Crinetics Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is CRNX. The reporting company's CIK number is 1658247.
The total value of stock buying since 2005 is $15,122,576.
The total value of stock sales since 2005 is $25,589,235.
The total value of stock option exercises since 2005 is $25,785.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2020-02-10||Vivo Opportunity Fund, L.p.||Sale||7,555||21.40||161,677|
|2020-02-07||Vivo Opportunity Fund, L.p.||Sale||5,905||22.00||129,910|
|2020-02-04||Vivo Opportunity Fund, L.p.||Sale||13,460||22.80||306,888|
|2020-01-31||Vivo Opportunity Fund, L.p.||Sale||5,400||21.70||117,180|
|2020-01-30||Vivo Opportunity Fund, L.p.||Sale||7,600||22.10||167,960|
|2020-01-29||Vivo Opportunity Fund, L.p.||Sale||13,920||22.20||309,024|
|2019-12-16||Fust Matthew K (Director)||Sale||3,500||22.50||78,750|
|2019-12-16||Fust Matthew K (Director)||Option Ex||3,500||1.91||6,685|
|2019-08-05||Struthers Richard Scott (President & CEO)||Option Ex||10,000||1.91||19,100|
|2019-06-21||Schwab Andrew J. (Other)||Sale||250,000||22.20||5,550,000|
|2019-03-20||Vivo Opportunity Fund, L.p.||Sale||417,000||22.25||9,278,250|
|2019-03-18||Schwab Andrew J. (10% Owner)||Sale||154,839||24.25||3,755,000|
|2019-01-22||Schwab Andrew J. (10% Owner)||Sale||262,153||21.88||5,734,596|
|2018-07-20||Vivo Opportunity Fund, L.p.||Buy||353,180||17.93||6,333,576|
|2018-07-20||Schwab Andrew J. (10% Owner)||Buy||115,000||17.00||1,955,000|
|2018-07-20||Krasner Alan Seth (Chief Medical Officer)||Buy||2,000||17.00||34,000|
|2018-07-20||Edelman Joseph (10% Owner)||Buy||400,000||17.00||6,800,000|
Insider trading activities including stock purchases, stock sales, and option exercises of CRNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Crinetics Pharmaceuticals, Inc. (symbol CRNX, CIK number 1658247) see the Securities and Exchange Commission (SEC) website.